About the Alliance

The Alliance for a Stronger FDA, created in 2007,  is a multi-stakeholder organization with 150+ members devoted to advocating for sufficient appropriations for the FDA and educating policymakers and the public about the FDA's mission and responsibilities. The Alliance’s unique coalition of patient and consumer groups and industry mirrors FDA’s unique role in public health, safety, and commerce.

Alliance Works For You

In a Letter to Members of Congress, The Alliance for a Stronger FDA Expresses Immediate Concern Concern Regarding Impacts of Proposed Reduction in FDA Resources

Washington, D.C. – The Alliance for a Stronger FDA, a coalition representing over 150 stakeholders, including consumer and patient groups, research advocates, health professions societies, industry leaders, and trade associations, today called on Congress to reconsider proposed reductions to FDA resources that could have wide-ranging consequences for public health, biomedical innovation, and economic growth.

In a letter addressed to key members of the House Energy and Commerce and Senate Health, Education, Labor, and Pensions Committee, the Alliance expressed deep concerns that changes to FDA staffing and resources could weaken the agency’s ability to efficiently regulate medical products, ensure food safety, and maintain U.S. leadership in global biomedical research.

“The FDA’s ability to safeguard public health and foster medical innovation depends on a highly skilled workforce and adequate resources,” said Cartier Esham, Executive Director of the Alliance for a Stronger FDA. “Reducing FDA staff and resources at this critical time will not lead to greater efficiency—it will instead stifle innovation, delay patient access to life-saving treatments, and jeopardize the safety of our nation’s food and medical supply.”

The letter urges congressional leaders to engage with Secretary of Health and Human Services Robert F. Kennedy, Jr.to assess the potential impact of these reductions and explore alternative solutions that support efficiency while preserving FDA’s critical functions. The Alliance also reaffirmed its commitment to working with policymakers to ensure the FDA has the flexibility and expertise needed to protect public health and maintain the nation’s global leadership in medical innovation.

The Alliance for a Stronger FDA Announces New Leadership Team for 2025

Alliance Releases its FY 25 “Ask” for FDA Funding

Highlighting The Alliance’s FDA Shutdown Tool Kit

Our Tool Kit has been updated as of September 29th 2024.

Catch Up on FDA Basics

How FDA is Funded: The Alliance for a Stronger FDA's primer on the agency’s resource needs.

Useful Links to FDA Website: